Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections

NCT04763759 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Prosthetic Joint Infection

Interventions

DRUG: TRL1068, a human monoclonal antibody

Sponsor

Trellis Bioscience LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]